CRVS — Corvus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Corvus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	69.5	42.3	27.1	52	56.8
Net Total Accounts Receivable
Net Total Receivables	0.539	0.633	0.063	0.216	0.374
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71.3	43.7	28	54.4	58.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.64	2.57	1.39	1.33	1.06
Long Term Investments
Other Long Term Assets
Total Assets	109	68.2	45.6	68.9	71.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.69	10.8	6.87	35.4	9.38
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.3	12.1	6.87	36.3	9.91
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	97.2	56.1	38.7	32.6	61.2
Total Liabilities & Shareholders' Equity	109	68.2	45.6	68.9	71.1
Total Common Shares Outstanding